Corient Private Wealth’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Corient Private Wealth's IRD Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Opus Genetics (IRD) in Q3 2026: 37,624 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #3032 among its holdings.
114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Corient Private Wealth held 37,624 shares of Opus Genetics worth $182K as of Q3 2026.
- Opus Genetics was a new Corient Private Wealth position in Q3 2026.
- Opus Genetics made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3032 holding.
- 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.